|
|
|
|
|
SIZE:
|
|
|
|
GENERIC NAME:
|
|
|
|
MANUFACTURER:
|
|
|
|
UNIT:
|
|
|
|
ADMINISTRATION ROUTE:
|
|
|
|
FDA PREGNANCY GROUP:
|
|
C
|
|
INDICATIONS:
|
|
Rejection, renal transplant, prophylaxis |
| |
|
|
SIDE EFFECTS:
|
|
Chest pain |
|
dyspnea |
|
fever |
|
hypertension |
|
hypotension |
|
nausea |
|
peripheral edema |
|
pulmonary edema |
|
tachycardia |
|
tremor |
|
vomiting |
|
weakness |
|
wound infection |
|
Hyperglycemia |
|
Arthralgia |
|
constipation |
|
diarrhea |
|
dizziness |
|
dyspepsia |
|
headache |
|
insomnia |
|
myalgia |
|
slow wound healing |
|
|
ABSOLUTE
CONTRAINDICATIONS :
|
|
|
|
RELATIVE
CONTRAINDICATIONS : |
|
Diabetes mellitus |
|
Infection |
|
Malignancy, current |
|
|
ADULT DOSE:
|
|
Transplant rejection, kidney (prophylaxis)-
Intravenous infusion over fifteen minutes, 1 mg per kg of body weight every fourteen days for five doses beginning no earlier than twenty-four hours prior to transplantation . |
|
MAXIMUM ADULT DOSE:
|
|
|
|
PEDIATRIC DOSE:
|
|
Transplant rejection, kidney (prophylaxis)-
Intravenous infusion over fifteen minutes, 1 mg per kg of body weight every fourteen days for five doses beginning no earlier than twenty-four hours prior to transplantation . |
|
MAXIMUM PEDIATRIC
DOSE:
|
|
|
|
ELDERLY DOSE:
|
|
Transplant rejection, kidney (prophylaxis)-
Intravenous infusion over fifteen minutes, 1 mg per kg of body weight every fourteen days for five doses beginning no earlier than twenty-four hours prior to transplantation . |
|
|
|
|